We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PSN:NYSEParsons Corporation Analysis

Data as of 2026-04-26 - not real-time

$53.45

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Parsons Corp. (PSN) is trading well beneath its 20‑day and 50‑day moving averages and also below the long‑term 200‑day SMA, indicating a bearish price trend. The RSI sits in the low‑mid 40s, suggesting momentum is still on the downside side of neutral, while the MACD line remains under its signal, reinforcing the bearish technical picture. Volatility over the past 30 days is elevated at over 40%, though the beta is sub‑1, implying the stock moves less than the market but with sizable swings. Fundamentals show a 7.5% revenue contraction and modest margins, yet the forward EPS outlook lifts the forward P/E to the mid‑teens, markedly lower than the trailing P/E and well under the industry average, which has prompted a consensus “Buy” rating. Cash generation remains solid with positive operating and free cash flow, and the balance sheet is manageable with a debt‑to‑equity under 50%. Recent material news highlights a new joint venture with a major partner and multiple contract wins in Europe, the Middle East, and the United States, pointing to potential top‑line upside. However, the discounted cash flow model values the company at roughly half its current market price, flagging a possible overvaluation in the short run.
In the medium to long term, the company’s deep ties to U.S. defense spending and its expanding digital infrastructure portfolio could provide a stable earnings runway, especially as forward earnings estimates improve. The lack of dividend payments eliminates income‑focused appeal, but the strategic positioning in high‑growth defense and infrastructure sectors may justify a “Buy” stance for investors with a longer horizon, provided they accept the current valuation premium.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 6/10

Key Factors

  • Price below key moving averages
  • Bearish MACD histogram
  • RSI indicating weak momentum

Medium Term

1–3 years
Neutral
Model confidence: 7/10

Key Factors

  • Forward earnings compression
  • Analyst consensus buy
  • New joint‑venture and contract wins

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • Long‑term defense spending tailwinds
  • Expansion of digital infrastructure services
  • Stable cash flow generation

Key Metrics & Analysis

Financial Health

Revenue Growth-7.50%
Profit Margin3.79%
P/E Ratio24.3
ROE11.65%
ROA4.65%
Debt/Equity49.76
P/B Ratio2.2
Op. Cash Flow$478.4M
Free Cash Flow$278.1M
Industry P/E38.1

Technical Analysis

TrendBearish
RSI41.5
Support$50.91
Resistance$59.00
MA 20$55.14
MA 50$58.06
MA 200$71.77
MACDBearish
VolumeStable
Fear & Greed Index88.02

Valuation

Fair Value$26.42
Target Price$74.80
Upside/Downside39.94%
GradeOvervalued
TypeBlend

Risk Assessment

Beta0.85
Volatility41.71%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.